|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Parkinson Disease | |||||
| 2 | More general conditions related to this trial | ||||
| Basal Ganglia Diseases | |||||
| Brain Diseases | |||||
| Central Nervous System Diseases | |||||
| Movement Disorders | |||||
| Nervous System Diseases | |||||
| Neurodegenerative Diseases | |||||
| Parkinsonian Disorders | |||||
| 3 | Interventions listed in this trial | ||||
| CEP-1347 | |||||
| 4 | Sponsors listed in this trial | ||||
| Cephalon | |||||
| H. Lundbeck A/S | |||||
| The Parkinson Study Group | |||||